Ng George K
Processa Pharmaceuticals, Inc. · Chief Executive Officer
Ng George K is listed in filings as Chief Executive Officer at Processa Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including purchase activity. Recent filings connect the profile to Processa Pharmaceuticals, Inc. (PCSA) and TuHURA Biosciences, Inc. - Common Stock (HURA). The current snapshot covers public activity from Jan 6, 2025 to Jun 1, 2026. Reported amounts are shown as $5.5K to $201.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $5.5k1.8k shares | BuyMay 15, 2026 | $2.97 | $2.64 | |
| $5.5k2k shares | BuyApr 30, 2026 | $2.69 | $2.64 | |
| $5.5k1.8k shares | BuyApr 15, 2026 | $2.97 | $2.64 | |
| $5.5k1.8k shares | BuyApr 15, 2026 | $2.97 | $2.64 | |
| $5.4k2.1k shares | BuyMar 31, 2026 | $2.54 | $2.64 | |
| $5.4k2.1k shares | BuyMar 31, 2026 | $2.54 | $2.64 | |
| $70k87.2k shares | BuyJan 27, 2025 | $0.7975 | $2.64 |